Glenmark Life Sciences IPO subscribed 6.48 times on final day, QIB portion booked 1.4 times
The initial public offering of Glenmark Life Sciences, a subsidiary of Glenmark Pharmaceuticals, was subscribed 7.1 times, getting bids for 10.65 crore equity shares against the IPO size of 1.5 crore shares by the morning of July 29, the last day of the…
